Shire Opts Not To Sue Teva Over Adderall XR ANDA
Shire Pharmaceuticals Group has decided not to sue Israeli generics maker Teva Pharmaceuticals USA Inc. over its application for a generic version of the best-selling attention deficit drug Adderall XR....To view the full article, register now.
Already a subscriber? Click here to view full article